Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

GSK holding history

GSK plc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
2,806,205
Value
$147.1M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,806,205$147.1M<0.1%+721,970+34.6%AddedHolders
Q1 20262,084,235$115.0M<0.1%−4,196,648−66.8%ReducedHolders
Q4 20256,280,883$308.0M0.1%+1,635,448+35.2%AddedHolders
Q3 20254,645,435$200.5M<0.1%−592,852−11.3%ReducedHolders
Q2 20255,238,287$201.2M<0.1%−2,633,768−33.5%ReducedHolders
Q1 20257,872,055$305.0M0.1%+1,388,847+21.4%AddedHolders
Q4 20246,483,208$219.3M<0.1%+5,819,167+876.3%AddedHolders
Q3 2024664,041$27.1M<0.1%−26,985−3.9%ReducedHolders
Q2 2024691,026$26.6M<0.1%+33,562+5.1%AddedHolders
Q1 2024657,464$28.2M<0.1%+109,022+19.9%AddedHolders
Q4 2023548,442$20.3M<0.1%−100,834−15.5%ReducedHolders
Q3 2023649,276$23.5M<0.1%+7,429+1.2%AddedHolders
Q2 2023641,847$22.9M<0.1%−386,038−37.6%ReducedHolders
Q1 20231,027,885$36.6M<0.1%−175,844−14.6%ReducedHolders
Q4 20221,203,729$42.3M<0.1%+190,273+18.8%AddedHolders
Q3 20221,013,456$29.8M<0.1%−263,737−20.6%ReducedHolders
Q2 20221,277,193$55.6M<0.1%+178,152+16.2%AddedHolders
Q1 20221,099,041$47.9M<0.1%−60,011−5.2%ReducedHolders
Q4 20211,159,052$51.1M<0.1%−6,079,888−84.0%ReducedHolders
Q3 20217,238,940$276.6M0.1%−202,026−2.7%ReducedHolders
Q2 20217,440,966$296.3M0.1%−961,914−11.4%ReducedHolders
Q1 20218,402,880$299.9M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.